SCHEMBL940190

SCHEMBL940190

Cc1ccc(Cl)c(S(=O)(=O)N(C)Cc2nc3cccc(C(=O)O)c3[nH]2)c1Cl

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM5A P29375 4/20 0.35
KDM5B Q9UGL1 4/20 0.35
KDM4A O75164 3/20 0.35
ALDH1A1 P00352 2/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
AKR1B10 O60218 1/20 0.34
ABCB11 O95342 1/20 0.34
TTR P02766 1/20 0.34
ADORA3 P0DMS8 1/20 0.34
CHRM1 P11229 1/20 0.34
FABP2 P12104 1/20 0.34
RXRA P19793 1/20 0.34
TBXA2R P21731 1/20 0.34
NR4A1 P22736 1/20 0.34
PTGS1 P23219 1/20 0.34
PDE4A P27815 1/20 0.34
MAPK1 P28482 1/20 0.34
PTGS2 P35354 1/20 0.34
AKR1C3 P42330 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL938977 0.90 C1R (0.36) KDM5AKDM5BKDM4AALDH1A1MEN1
SCHEMBL938966 0.90 PTGS2 (0.38) ALDH1A1MEN1KMT2AMAPK1PTGS2
SCHEMBL11947899 0.84 KDM5B (0.38) KDM5AKDM5BKDM4AALDH1A1LMNA
SCHEMBL940059 0.83 KDM4A (0.37) KDM5AKDM5BKDM4AALDH1A1MEN1
SCHEMBL941264 0.82 KDM4C (0.41) KDM5AKDM5BKDM4AALDH1A1TDP1
SCHEMBL940188 0.80 CLCN2 (0.38) KDM5AKDM5BKDM4AALDH1A1MEN1
SCHEMBL937728 0.80 KDM4E (0.35) ALDH1A1MEN1KMT2ANR4A2TDP1
SCHEMBL938222 0.79 CYP3A4 (0.39) ALDH1A1MAPK1SMN1; SMN2USP2
SCHEMBL11947897 0.77 DYRK1A (0.41) KDM5AKDM5BKDM4AALDH1A1MEN1
SCHEMBL940167 0.76 C1R (0.45) ALDH1A1MEN1KMT2ANR4A1NR4A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2440542-B1 Substituted benzimidazoles, benzonthiazoles and benzoxazoles GRUENENTHAL GMBH (DE) 2013-12-18 EP disclosed
US-8232288-B2 Substituted benzimidazoles, benzothiazoles and benzoxazoles GRUENENTHAL GMBH (DE) 2012-07-31 US disclosed
US-20110009382-A1 Substituted Benzimidazoles, Benzothiazoles and Benzoxazoles GRUENENTHAL GMBH (DE) 2011-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110009382-A1 Substituted Benzimidazoles, Benzothiazoles and Benzoxazoles BDKRB1, BDKRB2, BRD1 KDM5A 2668/4885KDM5B 2301/4885KDM4A 2323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.